DSS (DSS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$18.5M

Revenue (quarter)

$3.6M

Revenue growth (year over year)

−31.81%

Gross profit (trailing twelve months)

−$16.1M

Gross margin

−87.37%

Net income (trailing twelve months)

−$30.8M

Net income (quarter)

−$5.0M

Net income growth (year over year)

−93.13%

Net margin

−167.16%

Return on equity

−358.33%

EPS (trailing twelve months)

−$2.94

Book value per share

−$0.04

P/E (trailing twelve months)

—

Price to book

0.72

Debt to assets

87.64%

Payout ratio

—

Dividend yield

—

Company profile

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

• Is DSS (DSS) profitable?

  No. DSS reported a net loss of $30.8M over the trailing twelve months.

• How much revenue does DSS (DSS) make?

  DSS generated $18.5M in revenue over the trailing twelve months, down 31.81% year over year.

• How do I buy stock in DSS (DSS)?

  DSS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.